Aquis weekly movers: Shortwave Life Sciences plans clinical study

Shortwave Life Sciences (LON: PSY), which is developing treatments for anorexia nervosa, is planning a clinical human feasibility study on impact of Psilocybin on the disease. This should lead to a phase 1 clinical study. A digital asset treasury strategy will help to fund the core business. The executive team is being changed. The share price jumped by four-fifths to 0.225p.

Fintech company Amazing AI (LON: AAI) raised £1.04m at 1p/share. This will fund the Bitcoin treasury policy. The share price increased 71.4% to 1.5p.

- Advertisement -

Mendell Helium (LON: MDH) says potential acquisition M3 Helium confirmed that the dewatering of the Rost project in Kansas is about to start. However, drilling in Nebraska has been delayed by wet weather and equipment problems. Even so, the share price improved 21.4% to 2.125p.  

SulNOx Group (LON: SNOX) has signed an agreement with marine equipment distributor C-Quip Ltd to supply fuel emissions reduction product Sulnox Eco in the UK leisure marine market. The share price firmed 2.47% to 41.5p.

FALLERS

Vault Ventures (LON: VULT) is launching vSignal.ai, an AI analytics platform providing a unified view of digital asset markets. The share price fell 11.4% to 1.55p.

- Advertisement -

Vaultz Capital (LON: V3TC) chief executive Eric Benz has been appointed to the board. The share price dropped 7.84% to 5.875p.  

Astrid Intelligence (LON: ASTR) has issued 575.2 million shares to Oak Securities at 0.1p each. Astrid Intelligence director Olivia Edwards bought 17.5 million shares at 0.147p each. The share price declined 5.45% to 0.13p.

Latest News

More Articles Like This